Vanguard Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5M | Buy |
|
|||||
|
2025
Q1 | $94.5M | Sell |
|
|||||
|
2024
Q4 | $119M | Sell |
|
|||||
|
2024
Q3 | $121M | Buy |
|
|||||
|
2024
Q2 | $81.2M | Buy |
|
|||||
|
2024
Q1 | $73.3M | Buy |
|
|||||
|
2023
Q4 | $23.3M | Buy |
|
|||||
|
2023
Q3 | $11.8M | Buy |
|
|||||
|
2023
Q2 | $15.7M | Buy |
|
|||||
|
2023
Q1 | $13.4M | Buy |
|
|||||
|
2022
Q4 | $17.7M | Buy |
|
|||||
|
2022
Q3 | $17.2M | Buy |
|
|||||
|
2022
Q2 | $9.76M | Buy |
|
|||||
|
2022
Q1 | $11.7M | Buy |
|
|||||
|
2021
Q4 | $18.3M | Buy |
|
|||||
|
2021
Q3 | $9.75M | Buy |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|
|||||
|
2021
Q1 | $3.9M | Buy |
|